Showing results (1221-1230 of 1,373) with videos related to

Sort By:
Pageof 138
Blood|June 15, 2011
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trialsPeter M Fayers, Antonio Palumbo, Cyrille Hulin, et al.
Harvard Data Science Review|June 18, 2026
Statistics and AI - A Fireside Conversation, , Xihong Lin, et al.
British Journal of Haematology|May 26, 2021
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogeneticsSimon J Harrison, Aurore Perrot, Adrian Alegre, et al.
Clinical Immunology (Orlando, Fla.)|April 7, 2016
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple SclerosisMarion Salou, Bryan Nicol, Alexandra Garcia, et al.
The Lancet. Oncology|November 21, 2007
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialHervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2025
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort StudyAlexis Talbot, Cyrille Hulin, Aurore Perrot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trialCyrille Hulin, Thierry Facon, Philippe Rodon, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 22, 2002
Hot-electron influence on L-shell spectra of multicharged Kr ions generated in clusters irradiated by femtosecond laser pulsesS B Hansen, A S Shlyaptseva, A Y Faenov, et al.
Cancers|December 30, 2025
Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic DirectionsJiayu Liu, Yuxin Wang, Shichao Su, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2025
Real-World Utilization of Carfilzomib (Once or Twice Weekly) Initiated in Patients After a First Relapse Between 2017 and 2022 in France: An Analysis From a Large-Scale Epidemiology of Multiple MYeloma (EmmY) CohortCyrille Hulin, Karim Belhadj Merzoug, Bruno Royer, et al.
Pageof 138